QoL Devices Announces Richard Hinds as CEO

Richard Hinds, new CEO named for QoL Devices, creator of the Alvio® Respiratory Muscle Training System to be manufactured by ADM Tronics Unlimited, Inc. (OTCQB-ADMT).

Northvale, NJ – QoL Devices Inc., (“QoL”) www.qoldevices.com announced today that Richard Hinds has been named as Chief Executive Officer.  QoL Devices Inc. is the creator of the award winning Alvio® respiratory muscle training system, an all-in-one, respiratory muscle trainer, symptom tracker, and Bluetooth game controller that allows users to play your way to better breathing™. 

Hinds has over 15 years of experience in the medical field.  Prior to coming to QoL, he was part of the executive team of a non-invasive pulmonary gas exchange analyzer manufacturer in Orange County, California.  His responsibilities included serving as the medical director and management representative during which time the company successfully obtained MDSAP certification, was recognized by the World Health Organization, and successfully won a competitive subaward from the Food and Drug Administration (FDA) for innovative pediatric medical device development.  He has also served as the Deputy Director of the Lung Injury Division of the Shanghai Respiratory Research Institute.  Before that he worked at Mayo Clinic in Rochester, Minnesota in the Medical Intensive Care Unit and Anesthesia Clinical Research Unit.  He has co-authored several papers in scientific journals, including the Journal of the American Medical Association (JAMA).  He received a master’s degree from George Washington University in clinical research administration, studied immunology at Mayo Graduate School, and received his bachelor’s degree in respiratory therapy from the University of Mary

“Richard is the right leader for QoL,” said Bez Arkush, Founder of QoL.  “Richard’s extensive experience as a respiratory therapist, researcher, and medical device executive provides him with a unique set of skills that will help QoL accelerate the pace that we bring technologies to market.”

“Not only am I honored to work with our great team at QoL, but I am also excited about our manufacturing partnership with ADM Tronics Unlimited, Inc. (“ADMT”), which has over 50 years of experience manufacturing and innovating new technologies.  Its FDA-Registered and ISO-13485 Certified medical device manufacturing facility ensures our ability to scale quickly and reliably, an important part of our go-to-market strategy,” stated Hinds. 

About QoL Devices Inc.

QoL Devices Inc. was founded in 2012 with a focus on developing smart, connected, consumer and medical technologies that improve quality of life.   QoL is the creator of the Alvio® Respiratory Muscle Training System (www.alv.io).

About ADM Tronics

ADM Tronics Unlimited, Inc. (OTCQB-ADMT) is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and Eco-Friendly, Water-Based Formulations. The Company’s headquarters, laboratories, FDA-Registered medical device and manufacturing operations are in Northvale, NJ. ADMT’s multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as rapid 3-D prototyping, precision instrumentation and specialized software and peripherals, for research, development and commercialization of diversified technologies. Additional information is available at the Company’s website – admtronics.com.

Except for historical information contained herein, the matters set forth in this news release are “forward looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance.  Although ADMT believes the expectations reflected in such forward looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations.  Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases and other communications. The Company assumes no obligation to update information contained in this news release.

Contact: QoL Communications Team, (201) 604-3765, [email protected]